These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1562726)

  • 1. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.
    Wesselschmidt R; Likert K; Girard T; Wun TC; Broze GJ
    Blood; 1992 Apr; 79(8):2004-10. PubMed ID: 1562726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Higuchi DA; Wun TC; Likert KM; Broze GJ
    Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.
    Huang ZF; Wun TC; Broze GJ
    J Biol Chem; 1993 Dec; 268(36):26950-5. PubMed ID: 8262929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
    Wun TC; Kretzmer KK; Palmier MO; Day KC; Huang MD; Welsch DJ; Lewis C; Wolfe RA; Zobel JF; Lange GW
    Thromb Haemost; 1992 Jul; 68(1):54-9. PubMed ID: 1325078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site.
    Enjyoji K; Miyata T; Kamikubo Y; Kato H
    Biochemistry; 1995 May; 34(17):5725-35. PubMed ID: 7727433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.
    Wesselschmidt R; Likert K; Huang Z; MacPhail L; Broze GJ
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):661-9. PubMed ID: 8292716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells.
    Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC
    Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.
    Hamamoto T; Yamamoto M; Nordfang O; Petersen JG; Foster DC; Kisiel W
    J Biol Chem; 1993 Apr; 268(12):8704-10. PubMed ID: 8473315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
    Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.
    Jesty J; Wun TC; Lorenz A
    Biochemistry; 1994 Oct; 33(42):12686-94. PubMed ID: 7918495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profiling of recombinant tissue factor pathway inhibitor.
    Jeske W; Hoppensteadt D; Callas D; Koza MJ; Fareed J
    Semin Thromb Hemost; 1996; 22(2):213-9. PubMed ID: 8807720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
    Hamamoto T; Kisiel W
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
    Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
    J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S; Suylen DP; Rosing J; Hackeng TM
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.
    Nordfang O; Bjørn SE; Valentin S; Nielsen LS; Wildgoose P; Beck TC; Hedner U
    Biochemistry; 1991 Oct; 30(43):10371-6. PubMed ID: 1931960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.